Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis
NCT06231264 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 96
Last updated 2025-05-25
Summary
The aim of this study was to evaluate the efficacy and safety of transcutaneous electrical acustimulation in patients with mild to moderate ulcerative colitis.
Conditions
Interventions
- DEVICE
-
transcutaneous electrical acustimulation at treatment sites
A transcutaneous electrical stimulator (TEA) device applies a mild electric stimulation through the skin, similar to acupuncture at the treatment site. The precise stimulating sites are not described upon registration to reduce unblinding risk.
- DEVICE
-
transcutaneous electrical acustimulation at sham sites
A transcutaneous electrical stimulator (TEA) device applies a mild electric stimulation through the skin, similar to acupuncture at the sham treatment sites. The precise stimulating sites are not described upon registration to reduce unblinding risk.
Sponsors & Collaborators
-
Xijing Hospital
lead OTHER
Principal Investigators
-
Kaichun Wu · Xijing Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-19
- Primary Completion
- 2026-03-01
- Completion
- 2026-05-01
Countries
- China
Study Locations
More Related Trials
-
Clinical Study on the Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis With Depression
NCT05030064 ·Status: UNKNOWN ·Phase: NA
-
Long-term Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis
NCT07114159 ·Status: RECRUITING ·Phase: NA
-
The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis
NCT02435160 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (UC)
NCT05679622 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis
NCT03221036 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Fecal Microbiota Transplantation for Ulcerative Colitis Through Colonic Transendoscopic Enteral Tubing
NCT02998112 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Therapeutic Fecal Transplant on the Gut Microbiome in Children With Ulcerative Colitis
NCT02291523 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Fecal Microbiota Transplantation for Ulcerative Colitis
NCT03016780 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis
NCT03235752 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Intestinal Ultrasound in Monitoring the Response to Biological Therapy in Patients With Ulcerative Colitis
NCT05606939 ·Status: UNKNOWN
-
Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or Proctosigmoiditis
NCT01008423 ·Status: COMPLETED ·Phase: PHASE3
-
Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment
NCT06867042 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
NCT05507203 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors
NCT02171429 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot and Feasibility Study of Fecal Microbiota Transplantation for Ulcerative Colitis
NCT02058524 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
NCT02407236 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Fecal Microbiota Transplantation in Ulcerative Colitis
NCT03483246 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase 3 Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
NCT04176588 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis
NCT00620126 ·Status: COMPLETED ·Phase: PHASE3
-
Standardized Fecal Microbiota Transplantation for Ulcerative Colitis
NCT01790061 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Open-Label Adalimumab for Ulcerative Colitis Patients
NCT00421642 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2a Study to Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of AG011 in Ulcerative Colitis
NCT00729872 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease
NCT00269841 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Intestinal Microbiota Transplantation for Inflammatory Bowel Diseases
NCT03426683 ·Status: COMPLETED ·Phase: NA
-
Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis
NCT01545908 ·Status: COMPLETED ·Phase: PHASE2